University of Leeds Featured PhD Programmes
University of Southampton Featured PhD Programmes
University of Exeter Featured PhD Programmes
University of Warwick Featured PhD Programmes
University of Bristol Featured PhD Programmes
"city"×
10 miles

Immunology (city) PhD Projects, Programs & Scholarships

We have 5 Immunology (city) PhD Projects, Programs & Scholarships

  • "city" ×
  • Immunology×
  • clear all
Order by 
Showing 1 to 5 of 5
  Ph.D. Fellowship in Intestinal Innate Immunity and Host Defense Peptides
  Dr E Cobo
Applications accepted all year round

Funding Type

PhD Type

RESEARCH. One Ph.D. position is available immediately at the University of Calgary, Canada to study gut innate immunity contributed by host defense peptides and immunoregulation in the epithelial and leukocyte cross-talking in response to microbial pathogens.
  Single-Cell Analysis of γδ T cell Biotherapeutics in Tumour Microenvironment Organoids
  Dr C Tape, Dr E Sahai
Application Deadline: 29 November 2019

Funding Type

PhD Type

Colorectal cancer (CRC) is a devastating disease that that kills approximately 700,000 people worldwide every year (>16,000 in the UK).
  Antibody-drug conjugates (ADCs) for the treatment of solid tumours
  Dr S Karagiannis, Prof J Downward
Application Deadline: 29 November 2019

Funding Type

PhD Type

An Antibody-Drug Conjugate (ADC) comprises an antibody targeted toward a tumour cell surface antigen, coupled through a chemical linker to a highly-cytotoxic drug.
  Chemically editable 3D tumour microenvironments to explore and exploit tumour immunity
  Dr O Pearce, Dr B Schumann
Application Deadline: 29 November 2019

Funding Type

PhD Type

Immunotherapy of cancers may offer progression free survival that is not seen with conventional chemotherapies. However, immunological barriers present within the tumour reduce response rates to therapy.
  Radiation induced oxidative DNA damage and cancer immunology in NSCLC
  Dr C Hiley, Dr S Boulton
Application Deadline: 29 November 2019

Funding Type

PhD Type

Forty percent of all patients cured of cancer have radiotherapy as part of their treatment. Lung cancer is the most common cause of cancer death in the UK and in non-small cell lung cancer (NSCLC) radiotherapy is the standard of care for patients with stage III disease.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.